Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Gynecologic CancerHereditary Cancer Syndrome
Interventions
OTHER

Chatbot

A chatbot is a software program designed to simulate human conversation, typically via text. Chatbots utilize natural language processing to gather patient data, anticipate questions, and predict responses. In this study, the Chatbot will simulate a text-like conversation with patients via a smartphone and use this platform to deal with the time-consuming nature of family history collection. The chatbots can then triage the collected family history against medical guidelines to determine which patients warrant genetic testing. For those patients meeting criteria for genetic testing, the chatbot can offer pre-test education and assist physicians with ordering genetic testing for interested patients meeting high-risk criteria.

Trial Locations (4)

10038

RECRUITING

NYP Lower Manhattan Hospital, New York

10065

RECRUITING

Weill Cornell Medicine, New York

11215

RECRUITING

NYP Brooklyn Methodist Hospital, Brooklyn

11375

RECRUITING

NYP Medical Group Queens, Queens

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER